C
Chieh Lin Fu
Researcher at Cleveland Clinic
Publications - 12
Citations - 1569
Chieh Lin Fu is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 1396 citations.
Papers
More filters
Journal ArticleDOI
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Peter Hillmen,Neal S. Young,Jörg Schubert,Robert A. Brodsky,Gérard Socié,Petra Muus,Alexander Röth,Jeff Szer,Modupe O. Elebute,Ryotaro Nakamura,Paul Browne,Antonio M. Risitano,Anita Hill,Hubert Schrezenmeier,Chieh Lin Fu,Jaroslaw P. Maciejewski,Scott A. Rollins,Christopher F. Mojcik,Russell P. Rother,Lucio Luzzatto +19 more
TL;DR: Eculizumab is an effective therapy for PNH and Clinically significant improvements were found in the quality of life, as measured by scores on the Functional Assessment of Chronic Illness Therapy-Fatigue instrument and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire.
Journal ArticleDOI
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
Robert A. Brodsky,Neal S. Young,Elisabetta Antonioli,Antonio M. Risitano,Hubert Schrezenmeier,Jörg Schubert,Anna Gaya,Luke Coyle,Carlos M. de Castro,Chieh Lin Fu,Jaroslaw P. Maciejewski,Monica Bessler,Henk André Kroon,Russell P. Rother,Peter Hillmen +14 more
TL;DR: The beneficial effects of eculizumab treatment in patients with PNH are applicable to a broader population of PNH patients than previously studied and were independent of baseline levels of hemolysis and degree of thrombocytopenia.
Journal ArticleDOI
Histologic Transformation in an Untreated Waldenstrom's Macroglobulinemia After 14 Years: Case Report and Review of the Literature.
Elizabeth Blessing Elimimian,Nadeem Bilani,Maria Julia Diacovo,Skirmante Sirvaitis,Chieh Lin Fu +4 more
TL;DR: In this article, a 60-year-old man with lifelong untreated macroglobulinemia presented with minimally symptomatic transformation to diffuse large B-cell lymphoma (DLBCL), with an accompanying review of the literature.
Journal ArticleDOI
Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017
TL;DR: In this paper , the authors utilized National Cancer Data Base (NCDB) to identify variables contributing to the overall survival (OS) of over 14,000 WM patients treated at Commission on Cancer (CoC)-accredited cancer centers across USA.
Journal ArticleDOI
Determinants of overall survival (OS) of primary plasma cell leukemia (pPCL): A National Cancer Database (NCDB) analysis of years 2004 to 2009.
TL;DR: Being female, having less comorbidities, getting treatment at ACs, and having PI had significantly greater OS, and HSCT may be enormously under-utilized for pPCL patients in the real world setting is identified.